...
首页> 外文期刊>Journal of Molecular Histology >Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer
【24h】

Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer

机译:肺癌1(TSLC1)表达中抑癌基因的下调与结肠癌患者预后不良相关

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, has been reported to be frequently inactivated in a variety of human malignant tumors. The aim of this study was to detect TSLC1 expression in human colon cancer and to analyze its association with prognosis of patients with colon cancer. Using quantitative real-time PCR and Western blot analysis, we found significantly decreased expression of TSLC1 in primary colon tumor tissues (n = 30) compared with adjacent normal tissues. Immunohistochemistry analysis also found decreased TSLC1 expression in 41.3 % (33/80) colon tumor tissues. In clinicopathological analysis, loss of TSLC1 expression significantly correlated with female gender and lymph node metastasis of colon cancer patients (P 0.05). In addition, decreased expression of TSLC1 in tumors was found to be closely associated with a poor prognosis (P = 0.037, log-rank test), and multivariate analysis showed that lower TSLC1 protein expression was an independent prognostic factor for colon cancer patients. Our study suggests that down-regulated expression of TSLC1 may play an important role in the progression of colon cancer and TSLC1 expression may serve as a useful marker for the prognostic evaluation of patients with colon cancer.
机译:据报道,肺癌1(TSLC1)是一种新型的肿瘤抑制基因,它在多种人类恶性肿瘤中经常失活。这项研究的目的是检测人结肠癌中TSLC1的表达,并分析其与结肠癌患者预后的关系。使用定量实时PCR和Western印迹分析,我们发现与邻近的正常组织相比,原发性结肠肿瘤组织(n = 30)中TSLC1的表达显着降低。免疫组织化学分析还发现在41.3%(33/80)结肠肿瘤组织中TSLC1表达降低。在临床病理分析中,TSLC1表达的丧失与结肠癌患者的女性性别和淋巴结转移密切相关(P <0.05)。此外,发现肿瘤中TSLC1的表达降低与预后不良密切相关(P = 0.037,对数秩检验),多变量分析表明,较低的TSLC1蛋白表达是结肠癌患者的独立预后因素。我们的研究表明,下调TSLC1的表达可能在结肠癌的进展中起重要作用,而TSLC1的表达可能是结肠癌患者预后评估的有用标志。

著录项

  • 来源
    《Journal of Molecular Histology》 |2012年第6期|p.715-721|共7页
  • 作者单位

    Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;

    Department of Thoracic Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;

    Department of Pathology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;

    Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, People’s Republic of China;

    Department of Oncology, The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Harbin, 150001, People’s Republic of China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Tumor suppressor in lung cancer 1; Colon cancer; Prognosis; Human;

    机译:肺癌的肿瘤抑制因子1;结肠癌;预后;人类;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号